Testsealabs Quick Results Occult Blood (Hb/TF) Combo Rapid Test Kit

Name: Testsealabs Quick Results Occult Blood (Hb/TF) Combo Rapid Test Kit
Brand: HangZhou Testsea biotechnology Co., Ltd.
SKU: 2107001695

Zhejiang, ChinaHangZhou Testsea biotechnology Co., Ltd.

US$0.55-0.85

1,000 Pieces

Product profile

Customization

Available

Type

IVD Instrument

Product Name

Occult Blood (Hb/TF) Combo Test Kit

Model NO.

109906

Application

Tumor Markers Rapid Test

Specimen

Feces

Format

Cassette

Result Time

15 mins

Power Source

Manual

Warranty

24 months

After-sale Service

Online technical support

Material

Plastic

Shelf Life

24 months

Quality Certification

ISO

MOQ

1000pcs

OEM/ODM

Available

Storage

4-30℃

Transport Package

Cartons

Trademark

Testsealabs

Origin

China

Company profile

HangZhou Testsea biotechnology Co., Ltd.

Zhejiang, China

CertifiedBusiness Type: Manufacturer/Factory & Trading Company CertifiedR&D Capacity: ODM Service Available & OEM Service AvailableExport Year: 2022-04-08Nearest Port: Shanghai, Ningbo, ShenzhenAverage Response Time: ≤8.91h CertifiedTerms of Payment: LC, T/T, D/P

AI-Powered supplier vetting

SummaryTestsea Biotechnology, based in Hangzhou, China, is a company founded in 2015 specializing in the R&D, production, and sale of in vitro diagnostic and veterinary products. The company holds ISO 9001 and GMP certifications, indicating robust quality management systems. With over 10 production lines and an annual production output between US$50 million and US$100 million, Testsea demonstrates substantial production capability. The company exports extensively, with 90% of sales derived from international markets. Testsea emphasizes innovation through its development of core technologies for diagnostic testing and offers a wide range of rapid test products.

Supplier typeTestsea Biotechnology is a trading company and manufacturer/factory based in Zhejiang, China.

CertificationsThe company holds ISO 9001 and GMP certifications, indicating adherence to quality management standards.

R&D capabilityThe company focuses on R&D and has built detection platforms, indicating strong innovation capabilities.

Production capacityWith over 10 production lines and an annual output of US$50M - US$100M, the company has substantial production capacity.

Client casesThe company's products are used globally in over 100 countries for various rapid diagnostic applications.